Ahmed NEDZHIB, Liudmil ANTONOV, Ivayla PANTCHEVA

Oxime-containing acetylcholinesterase reactivators and their complexes with Pd(II) and Pt(II) ions: recent developments

The ability of oxime-containing acetylcholinesterase reactivators BT-07 (K005), BT-08 (K033), BT-07-4M (K074), and obidoxime $(H_2 LX_2 , X = Cl − , Br −)$ to bind palladium(II) or platinum(II) cations was evaluated in aqueous solutions (pH 7.4) at metal-to-ligand molar ratio varying from 1:10 to 10:1. Spectral changes were monitored within a week after mixing the reagents in the range from 220 nm to 500 nm. Results showed that depending on chemical structure and reaction time, oximes form two complex species of composition, $[MHL] ^{3+} or [M_2 L] ^{4+} (M = Pd(II), Pt(II))$. It was also found that complexation of platinum(II) ions proceeds slower as compared to palladium(II). Conditional stability constants of new complex species were determined spectrophotometrically using an advanced chemometric procedure, based on the resolution of overlapping bands technique.

PDF

___

1. World Health Organization. Health Aspects of Chemical and Biological Weapons: Report of a WHO Group of Consultants. World Health Organization: Geneva, Switzerland, 1970.
2. Munro, N. B.; Ambrose, K. R.; Watson, A. P. Environ. Health Persp. 1994, 102, 18-37.
3. Kamanyire, R.; Karalliedde, L. Occup. Med. 2004, 54, 69-75.
4. Balali-Mood, M.; Balali-Mood, K. Arch. Iran. Med. 2008, 11, 65-89.
5. Sidell, F. R.; Borak, J. Ann. Emerg. Med. 1992, 21, 865-871.
6. Park, S. E.; Kim, N. D.; Yoo, Y. H. Cancer Res. 2004, 64, 2652-2655.
7. Newmark, J. Neurol. Clin. 2005, 23, 623-641.
8. Balali-Mood, M.; Balali-Mood, K.; Hosseini, S. F. Iran. J. Pharm. Res. 2006, 5, 79-87.
9. Balali-Mood, M.; Saber, H. Iran. J. Med. Sci. 2012, 37, 74-91.
10. Kuca, K.; Bielavsky, J.; Cabal, J.; Kassa, J. Bioorg. Med. Chem. Lett. 2003, 13, 3545-3547.
11. Kassa, J.; Bajgar, J. Hum. Exp. Toxicol. 1996, 15, 383-388.
12. Kassa, J.; Vachek, J. Toxicology 2002, 177, 179-185.
13. Bajgar, J. J. Med. Chem. Def. 2003, 1, 1-15.
14. Inns, R. H.; Leadbeater, L. J. Pharm. Pharmacol. 1983, 35, 427-433.
15. Reiner, E. Croat. Chem. Acta 1986, 59, 925-931.
16. Reiner, E.; Simeon-Rudolf, V. Arh. Hig. Rada. Toksiko. 2006, 57, 171-179.
17. Kassa, J. J. Toxicol. Clin. Toxicol. 2002, 40, 803-816.
18. Kassa, J.; Kuca, K.; Cabal, J. Biologia 2005, 17, 77-79.
19. Bajgar, J. Adv. Clin. Chem. 2004, 38, 151-216.
20. Antonjevic, B.; Stojiljkovic, M. P. Clin. Med. Res. 2007, 5, 71-82.
21. Jokanovic, M.; Stojiljkovic, M. Eur. J. Pharmacol. 2006, 553, 10-17.
22. Eyer, P.; Worek, F. In Chemical Warfare Agents: Toxicology and Treatment, 2nd ed.; Marrs, T. M.; Maynard, R. L.; Sidell, F., Eds. Wiley and Sons: Chichester, UK, 2007, pp. 277-303.
23. Milatovic, D.; Jokanovi´c, M. In Handbook of Toxicology of Chemical Warfare Agents; Gupta, R. G., Ed. Elsevier: London, UK, 2009, pp. 985-996.
24. Masson, P. Toxicol. Lett. 2011, 206, 5-13.
25. Schoene, K.; Oldiges, H. Arch. Int. Pharmacod. T. 1973, 204, 110-123.
26. Maksimovic, M.; Kovacevic, V. Acta Pharm. Jugosl. 1989, 39, 27-33.
27. Mesic, M.; Deljac, A.; Deljac, V.; Binenfield, Z.; Kilibarda, V.; Maksimovic, M.; Kovacevic, D. Acta Pharm. Jugosl. 1991, 203-210.
28. Masuda, N.; Takatsu, M.; Morinari, H.; Ozawa, T. Lancet 1995, 345, 1446.
29. Jong, L. P. A.; Verhagen, M. A. A.; Langenberg, J. P.; Hagedorn, I.; L¨offler, M. Biochem. Pharmacol. 1989, 38, 633-640.
30. Martell, A. E.; Hancock, R. D. In Metal Complexes in Aqueous Solutions. Modern Inorganic Chemistry; Fackler, J. P. Jr., Ed. Springer: Boston, MA, USA, 1996, pp. 149-197.
31. Sadler, P. J.; Guo, Z. Pure Appl. Chem. 1998, 70, 863-871.
32. Gasser, G. CHIMIA, 2015, 7, 442-446.
33. Cier, A.; Cuisinaud, G.; Solal, M.; Rossi, C. B. Soc. Chim. Biol. (Paris) 1969, 51, 753-762.
34. Karljikovic-Rajic, K.; Stankovi´c, B.; Binenfeld, Z. J. Pharmaceut. Biomed. 1987, 5, 141-149.
35. Karljikovic-Rajic, K.; Stankovi´c, B.; Granov, A.; Binenfeld, Z. J. Pharmaceut. Biomed. 1988, 6, 773-780.
36. Karljikovic-Rajic, K.; Stankovi´c, B.; Granov, A. J. Pharmaceut. Biomed. 1990, 8, 735-738.
37. Koricanak, Z.; Karljikovi´c-Raji´c, K.; Stankovic, B. Talanta 1990, 5, 535-537.
38. Karljikovic-Rajic, K. D.; Rajkovic, M. B. B. Electrochem. 1997, 13, 83-87.
39. Foretic, B.; Piceka, I.; Damjanovic, V.; Cvijanovic, D.; Pulic, I.; Kukovec, B. M.; Matkovic-Calogovic, D. Polyhedron 2013, 52, 733-742.
40. Nedzhib, A.; Stoykova, S.; Atanasov, V.; Pantcheva, I.; Antonov, L. Interdiscip. Toxicol. 2014, 7, 101-107.
41. Musılek, K.; Lipka, L.; Racakova, V.; Kuca, K.; Jun, D.; Dohnal, V.; Dolezal, M. Chem. Pap. 2006, 60, 48-51.
42. Kuca, K.; Cabal, J.; Patocka, J.; Kassa, J. Lett. Org. Chem. 2004, 1, 84-86.
43. Jokanovic, M. Curr. Top. Med. Chem. 2012, 12, 1775-1789.
44. Hirose, K. In Analytical Methods in Supramolecular Chemistry, 2nd Ed.; Schalley, C., Ed. Wiley-VCH: Weinheim, Germany, 2012, pp. 27-66.
45. Sinko, G.; Calic, M.; Kovarik, Z. ˇ FEBS Lett. 2006, 580, 3167-3172.
46. Singh, N. PhD, Pt. Ravishankar Shukla University, Raipur, India, 2012.
47. Gillam, A. E.; Stern, E. S.; Timmons, C. J. Gillam and Stern’s Introduction to Electronic Absorption Spectroscopy in Organic Chemistry. Edward Arnold: London, UK, 1970.
48. Odzak, R; Calic, M; Hrenar, T.; Primozic, I.; Kovarik, Z. Toxicology 2007, 233, 85-96.
49. Antonov, L.; Nedeltcheva, D. Anal. Lett. 1996, 29, 2055-2069.
50. Antonov, L.; Nedeltcheva, D. Chem. Soc. Rev. 2000, 29, 217-227.
51. Antonov, L.; Petrov, V. Anal. Bioanal. Chem. 2002, 374, 1312-1317.
52. Britton, H. T. S.; Robinson, R. A. J. Chem. Soc. 1931, 1456-1652.
53. Coch-Frugoni, J. A. Gazz. Chim. Ital. 1957, 87, 403-407.